Exousia Bio, Inc. (LMMY) earnings
Quarterly results of Exousia Bio, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended November 30, 2025) Exousia Bio, Inc. reported revenue of $0 and a net loss of $19.1K.
Diluted earnings per share were $0.00.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $0 | - | -$19.1K | $0.00 |
| Q1 FY2026 | $0 | - | -$31.8K | $0.00 |
| Q4 FY2025 | $0 | - | -$86.7K | - |
| Q3 FY2025 | $0 | - | $61.8K | - |
| Q2 FY2025 | $0 | - | $80.1K | $0.01 |
| Q1 FY2025 | $3.8K | - | -$3.9K | $0.00 |
| Q4 FY2024 | $3.8K | - | -$5.3K | - |
| Q3 FY2024 | $3.9K | - | -$4.8K | $0.00 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
What were Exousia Bio, Inc.'s latest quarterly results?
For Q2 FY2026, which ended November 30, 2025, Exousia Bio, Inc. reported revenue of $0 and a net loss of $19.1K. The figures come from its filing with the SEC.
Get an email when LMMY reports
Follow LMMY and we email you its next results the day they are filed, with the numbers explained.